| A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorub | Phase II | rekrutiert |
| A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis | Phase II | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Co | Phase II / Phase III | rekrutiert |
| A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A | Phase I | rekrutiert |
| A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia | Phase I / Phase II | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head | Phase III | rekrutiert |
| A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesit | Phase III | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa | — | rekrutiert |
| A Non-interventional, Prospective Study With Benralizumab | — | rekrutiert |
| A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With De | Phase I / Phase II | rekrutiert |
| A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Prev | Phase III | rekrutiert |
| A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treat | Phase III | rekrutiert |
| A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Pl | Phase III | rekrutiert |
| A Platform Study in Non-Small Cell Lung Cancer (NSCLC) | Phase I / Phase II | rekrutiert |
| A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart | Phase III | rekrutiert |
| A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD | Phase III | rekrutiert |
| A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antib | Phase III | rekrutiert |
| A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carbopla | Phase III | rekrutiert |
| A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NAS | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab a | Phase III | rekrutiert |
| A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD | Phase III | rekrutiert |
| A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) | Phase II | rekrutiert |
| A Study of AZD0120 in Autoimmune Diseases | Phase I | rekrutiert |
| A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell | Phase I / Phase II | rekrutiert |
| A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Ch | Phase III | rekrutiert |
| A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epider | Phase II | rekrutiert |
| A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced So | Phase I / Phase II | rekrutiert |
| A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Adva | Phase II | rekrutiert |
| A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone | Phase III | rekrutiert |
| A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagn | Phase III | rekrutiert |
| A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treate | — | rekrutiert |
| A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection Af | — | rekrutiert |
| A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men | Phase III | rekrutiert |
| A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic No | Phase II | rekrutiert |
| A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthriti | Phase III | rekrutiert |
| A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory M | — | rekrutiert |
| A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Pati | Phase III | rekrutiert |
| A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma | Phase II | rekrutiert |
| A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab | Phase III | rekrutiert |
| A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoP | — | rekrutiert |
| A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Phase III | rekrutiert |
| A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemot | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRI | Phase II | rekrutiert |
| A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associa | Phase III | rekrutiert |
| A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzuma | Phase II / Phase III | rekrutiert |
| A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in | Phase I / Phase II | rekrutiert |
| A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma | Phase I | rekrutiert |
| A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult an | Phase III | rekrutiert |
| A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism | Phase III | rekrutiert |
| A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy | Phase I / Phase II | rekrutiert |
| A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previous | Phase III | rekrutiert |
| A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Par | Phase II | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of The | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Parti | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + | Phase III | rekrutiert |
| A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia | Phase III | rekrutiert |
| A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bort | Phase III | rekrutiert |
| A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting | Phase I / Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants Wit | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Mul | Phase II | rekrutiert |
| A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Mar | Phase III | rekrutiert |
| A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Foc | Phase III | rekrutiert |
| A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotocl | Phase III | rekrutiert |
| A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adu | Phase III | rekrutiert |
| A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 | Phase II | rekrutiert |
| A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other | Phase I | rekrutiert |
| A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Can | Phase I | rekrutiert |
| A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosu | Phase III | rekrutiert |
| A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD | Phase II | rekrutiert |
| A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Ri | Phase III | rekrutiert |
| ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or | Phase I / Phase II | rekrutiert |
| AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple My | Phase I / Phase II | rekrutiert |
| AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia | Phase I / Phase II | rekrutiert |
| AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate | Phase III | rekrutiert |
| AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematolo | Phase I / Phase II | rekrutiert |
| Adrenal Tumors - Pathogenesis and Therapy | — | rekrutiert |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leuka | Phase II / Phase III | rekrutiert |
| An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Mode | Phase III | rekrutiert |
| An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly | — | rekrutiert |
| An Open-label Study of AZD0120 in Adults With Multiple Sclerosis | Phase I | rekrutiert |
| Analysis of TPE Treatments With multiFiltratePRO | — | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study | — | rekrutiert |
| Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting | ohne Phasenangabe | rekrutiert |
| Auricular Acupuncture in Patients With Advanced Cancer: a Randomized Clinical Trial. | ohne Phasenangabe | rekrutiert |
| BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs | — | rekrutiert |
| BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatmen | — | rekrutiert |
| Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected St | Phase III | rekrutiert |
| Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreat | Phase II | rekrutiert |
| Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseContr | ohne Phasenangabe | rekrutiert |
| Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET) | — | rekrutiert |
| Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa | Phase II | rekrutiert |
| CAR-T Long Term Follow Up (LTFU) Study | Phase III | rekrutiert |
| CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer | — | rekrutiert |
| CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitu | Phase III | rekrutiert |
| COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer | — | rekrutiert |
| COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Heal | — | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Clinical Performance of the New Plasma Filter PX2 in TPE Treatments | ohne Phasenangabe | rekrutiert |
| ColoReg: A Register for Gastrointestinal Endoscopy Reports and Examination Videos | — | rekrutiert |
| Corheart 6 LVAS Study | ohne Phasenangabe | rekrutiert |
| DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig P | Phase III | rekrutiert |
| DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to C | Phase III | rekrutiert |
| Deep Brain Stimulation (DBS) Retrospective Outcomes Study | — | rekrutiert |
| Dexamethasone Eluting Cochlear Implant: a Pivotal Study | ohne Phasenangabe | rekrutiert |
| Dystonia Image-based Programming of Stimulation: A Prospective, Randomized, Double-blind Crossov | ohne Phasenangabe | rekrutiert |
| EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagl | Phase III | rekrutiert |
| ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP) | — | rekrutiert |
| Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponat | Phase IV | rekrutiert |
| Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort | — | rekrutiert |
| European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] | Phase II | rekrutiert |
| Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Me | Phase II / Phase III | rekrutiert |
| Evaluation of HEArt invoLvement in Patients With FABRY Disease | — | rekrutiert |
| Existential Distress in Advanced Cancer: Comparing a Short-term Psychodynamic Psychotherapy (ORP | ohne Phasenangabe | rekrutiert |
| Exploratory Investigation of the Acceptance and Utility of 14-day Trial Periods and Application- | ohne Phasenangabe | rekrutiert |
| Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Pa | Phase II / Phase III | rekrutiert |
| Fabry Disease Registry & Pregnancy Sub-registry | — | rekrutiert |
| GISAR German Interdisciplinary Sarcoma Registry | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5 | Phase II | rekrutiert |
| Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITIO | Phase II | rekrutiert |
| German Adrenocortical Carcinoma Registry | — | rekrutiert |
| German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm) | — | rekrutiert |
| Giant Cell Arteritis - Ways to Precision Medicine | — | rekrutiert |
| HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT) | Phase III | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL | Phase III | rekrutiert |
| ITP Registry and Accompanying Biospecimen Collection | — | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Phase II | rekrutiert |
| Impact of a High-fiber Diet on the Microbiome and Disease Activity in Patients With Rheumatoid A | ohne Phasenangabe | rekrutiert |
| Implantation of Engineered Cartilage Grafts for Treatment of Patellofemoral Osteoarthritis Versu | Phase II | rekrutiert |
| Improved Management of Patients With Recent-Onset Stable Chest Pain | ohne Phasenangabe | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to | ohne Phasenangabe | rekrutiert |
| Investigating the Mechanisms of Decision-Making Using Non-Invasive Brain Stimulation | ohne Phasenangabe | rekrutiert |
| KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors | Phase I | rekrutiert |
| LEOPARD Training and Validation Data Collection Study | — | rekrutiert |
| LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Cal | Phase III | rekrutiert |
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MAS | Phase III | rekrutiert |
| Liquid Biopsy Under PSMA Radioligand Therapy | — | rekrutiert |
| Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells | Phase II / Phase III | rekrutiert |
| Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies | ohne Phasenangabe | rekrutiert |
| Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRA | Phase III | rekrutiert |
| Lymphatic Organs and Myocardium After Myocardial Infarction | ohne Phasenangabe | rekrutiert |
| MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Card | Phase III | rekrutiert |
| Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Ge | Phase III | rekrutiert |
| Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I | Phase III | rekrutiert |
| Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory M | Phase III | rekrutiert |
| Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections | Phase III | rekrutiert |
| Neoadjuvant Darovasertib in Primary Uveal Melanoma | Phase III | rekrutiert |
| Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab | Phase II | rekrutiert |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma | Phase II | rekrutiert |
| Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis | — | rekrutiert |
| Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associa | — | rekrutiert |
| Non-invasive Detection of Iron Deficiency in Obstetrics | — | rekrutiert |
| Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) | Phase III | rekrutiert |
| PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After | ohne Phasenangabe | rekrutiert |
| PROCARE - PROstate Cancer Real World Evidence Registry | — | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| PSMA in Gastroenterologic Tumors (GIPSMA) | ohne Phasenangabe | rekrutiert |
| Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta | Phase III | rekrutiert |
| Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line T | — | rekrutiert |
| Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Mali | Phase I | rekrutiert |
| Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma | Phase I / Phase II | rekrutiert |
| Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Ca | Phase III | rekrutiert |
| Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenal | Phase III | rekrutiert |
| Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region | — | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |
| Praegnant Breast Cancer: Early/Advanced/Metastatic | — | rekrutiert |
| Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Hea | — | rekrutiert |
| Pulmonary Hemodynamics During Exercise - Research Network | — | rekrutiert |
| Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for C | — | rekrutiert |
| Radiotherapy of Head and Neck Cancer With SIB | — | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia | Phase III | rekrutiert |
| Rapid Point-of-care Bacteriuria and Microbial Susceptibility for Women With Suspected Uncomplica | — | rekrutiert |
| Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Pro | — | rekrutiert |
| Registry for Hypoparathyroidism Wuerzburg | — | rekrutiert |
| Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry | — | rekrutiert |
| STIMPulseControl Ancillary Speech Study | ohne Phasenangabe | rekrutiert |
| Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in | ohne Phasenangabe | rekrutiert |
| Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Ther | Phase II / Phase III | rekrutiert |
| Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-re | Phase II | rekrutiert |
| Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI) | ohne Phasenangabe | rekrutiert |
| Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy | — | rekrutiert |
| Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced | Phase III | rekrutiert |
| Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior | — | rekrutiert |
| Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN | Phase III | rekrutiert |
| Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma | Phase I / Phase II | rekrutiert |
| Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Folli | Phase III | rekrutiert |
| Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung | Phase I | rekrutiert |
| Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis | ohne Phasenangabe | rekrutiert |
| Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe General | Phase III | rekrutiert |
| Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Co | Phase I / Phase II | rekrutiert |
| Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308 | Phase I | rekrutiert |
| Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL | Phase II | rekrutiert |
| TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardio | Phase III | rekrutiert |
| Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemi | Phase I / Phase II | rekrutiert |
| Taper Or Abrupt Steroid Stop: TOASSTtrial | Phase IV | rekrutiert |
| The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in I | Phase III | rekrutiert |
| The DefiPace Study | — | rekrutiert |
| The European NAFLD Registry | — | rekrutiert |
| The German ADPKD Tolvaptan Treatment Registry | — | rekrutiert |
| The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill | Phase III | rekrutiert |
| Trabeculopuncture as Predictive Test for the Success of Ab Interno Trabeculectomy | ohne Phasenangabe | rekrutiert |
| Training Physicians to Differentiate the Paris Classification Using Artificial Colon Polyp Image | ohne Phasenangabe | rekrutiert |
| Treatment Guided by Comprehensive Genome and Transcriptome Analysis Versus Standard of Care in A | — | rekrutiert |
| Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells V | Phase III | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage. | Phase II | rekrutiert |
| Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Partic | Phase II | rekrutiert |
| Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Partici | Phase II | rekrutiert |
| Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephali | Phase II | rekrutiert |
| Ultra-high-caloric, Fatty Diet in ALS | ohne Phasenangabe | rekrutiert |
| Vascular MRI Evaluation in Giant Cell Arteritis (VEGA) | — | rekrutiert |
| Vercise™ DBS Dystonia Prospective Study | — | rekrutiert |
| Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Ha | Phase III | rekrutiert |
| Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocri | Phase II / Phase III | rekrutiert |